We have located links that may give you full text access.
Patient parameters and other radiation safety issues in 131I therapy for thyroid cancer treatment.
Health Physics 2007 December
Patients administered with a therapeutic dose of I for thyroid cancer treatment are potential sources of unacceptably high radiation exposure to other individuals, particularly the patient's immediate family members. Generally, patients are hospitalized until such time that the retained radioactivity in the body or the measured dose rate at 1 m from the patient's body surface fall to within acceptable levels. Patient release criteria are set to ensure that no individual shall be liable to receive exposures above the regulatory dose limit for the public or dose constraints for the patient's relatives or caregivers.
Full text links
Related Resources
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app
All material on this website is protected by copyright, Copyright © 1994-2024 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.
By using this service, you agree to our terms of use and privacy policy.
Your Privacy Choices
You can now claim free CME credits for this literature searchClaim now
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app